Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study

MLA

Juhee Cho, et al. “Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study.” Cardiovascular Drugs and Therapy, vol. 37, Sept. 2021, pp. 141–50. EBSCOhost, https://doi.org/10.1007/s10557-021-07256-1.

APA

Juhee Cho, Joo Myung Lee, Jin-Ho Choi, Danbee Kang, Ki Hong Choi, Minwoong Kang, Jeong Hoon Yang, Seung-Hyuk Choi, Young Bin Song, Hyeon Cheol Gwon, Eliseo Guallar, Juwon Kim, Hyejeong Park, Joo Yong Hahn, & Taek Kyu Park. (2021). Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study. Cardiovascular Drugs and Therapy, 37, 141–150. https://doi.org/10.1007/s10557-021-07256-1

Chicago

Juhee Cho, Joo Myung Lee, Jin-Ho Choi, Danbee Kang, Ki Hong Choi, Minwoong Kang, Jeong Hoon Yang, et al. 2021. “Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study.” Cardiovascular Drugs and Therapy 37 (September): 141–50. doi:10.1007/s10557-021-07256-1.